Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy

References

• Aditya NP, Macedo AS, Doktorovova S, et al. (2014). Development and evaluation of lipid nanocarriers for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE). LWT-Food Sci Technol 59:115–21.
   Web of Science ®Google Scholar
• Allen LV, Erickson MAJ. (2011). Stability of extemporaneously prepared pediatric formulations using Ora-Plus with Ora-Sweet SF-Part II. Secundum Artem 6.
   Google Scholar
• Amidon GL, Lennernas H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–20.
   PubMed Web of Science ®Google Scholar
• Armand M, Hamosh M, Mehta NR, et al. (1996). Effect of human milk or formula on gastric function and fat digestion in the premature infant. Pediatr Res 40:429–37.
   PubMed Web of Science ®Google Scholar
• Asif M, Jabeen Q, Abdul-Majid AM, Atif M. (2014). Diuretic activity of Boswellia serrata Roxb. oleo gum extract in albino rats. Pak J Pharm Sci 27:1811–17.
   PubMed Web of Science ®Google Scholar
• Associazione Ospedali Pediatrici Italiani, 2005. L’allestimento di preparati farmaceutici personalizzati nelle UUOO di farmacia degli ospedali pediatrici italiani. Bollettino SIFO 5 212-218. Il Pensiero Scientifico Ed.
   Google Scholar
• Atienza M, Martínez J, Álvarez C. 2011. Formulación en farmacia pediátrica. Madrid: A. Madrid Vicente
   Google Scholar
• Attama AA, Schicke BC, Müller-Goymann CC. (2006). Further characterization of theobroma oil–beeswax admixtures as lipid matrices for improved drug delivery systems. Eur J Pharm Biopharm 64:294–306.
   PubMed Web of Science ®Google Scholar
• Atthaporn B. (2011). Biocompatibility study of glycofurol in rat brains. Exp Biol Med 236:77–83.
   Web of Science ®Google Scholar
• Basant Kumar Reddy B, Karunakar A. (2011). Biopharmaceutics classification system: a regulatory approach. Dissolution Technol 18:3–37.
   Web of Science ®Google Scholar
• Batchelor HK, Kendall R, Desset-Brethes S, et al. (2013). Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients. Eur J Pharm Biopharm 85:833–42.
   PubMed Web of Science ®Google Scholar
• Batchelor HK, Fotaki N, Klein S. (2014). Paediatric oral biopharmaceutics: key considerations and current challenges. Adv Drug Deliv Rev 73:102–26.
   PubMed Web of Science ®Google Scholar
• Beloqui A, Solinís MA, Rodríguez-Gascón A, et al. (2016). Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine: Nanotech Biol Med 12:143–61.
   PubMed Web of Science ®Google Scholar
• Bernback S, Blackberg L, Hernell O. (1990). The complete digestion of human milk triacylglycerol in vitro requires gastric lipase, pancreatic colipase-dependent lipase, and bile salt-stimulated lipase. J Clin Invest 85:1221–6.
   PubMed Web of Science ®Google Scholar
• Bhupinder K, Newton MJ. (2016). Impact of Pluronic-F68 vs Tween180 on fabrication and evaluation of acyclovir SLNs for skin delivery. Recent Patents Drug Deliv Formul 10:1–15.
   Google Scholar
• Boehm G, Bierbach U, Senger H, et al. (1991). Activities of lipase and trypsin in duodenal juice of infants small for gestational age. J Pediatr Gastroenterol Nutr 12:324–7.
   PubMed Web of Science ®Google Scholar
• Carriere F, Barrowman JA, Verger R, Laugier R. (1993). Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105:876–88.
   PubMed Web of Science ®Google Scholar
• Chaturvedi SP, Kumar V. (2012). Production techniques of lipid nanoparticles: a review res. J Pharm Biol Chem Sci 3:525–41.
   Google Scholar
• Cirri M, Bragagni M, Mennini N, Mura P. (2012). Development of a new delivery system consisting in” drug-in cyclodextrin-in nanostructured lipid carriers” for ketoprofen topical delivery. Eur J Pharm Biopharm 80:46–53.
   PubMed Web of Science ®Google Scholar
• Cirri M, Mennini N, Maestrelli F, et al. (2017). Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Int J Pharm 521:73–83.
   PubMed Web of Science ®Google Scholar
• Compaore M, Lamien-Meda A, Mogoşan C, et al. (2011). Antioxidant: diuretic activities and polyphenol content of Stereospermum kunthianum Cham.(Bignoniaceae). Nat Prod Res 25:1777–88.
   PubMed Web of Science ®Google Scholar
• Danamma KAK, Jayasimha BG, Basha SN. (2011). Diuretic activity and study of biochemical parameters in the methanol extract of Hibiscus esculentus (Okra) fresh fruits. Int J Pharm Biol Sci 1:160–9.
   Google Scholar
• Das S, Chaudhury A. (2011). Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharm Sci Tech 12:62–76.
   PubMed Web of Science ®Google Scholar
• Di Palma J, Kirk CL, Hamosh M, et al. (1991). Lipase and pepsin activity in the gastric mucosa of infants, children, and adults. Gastroenterology 101:116–21.
   PubMed Web of Science ®Google Scholar
• Food Safety Commission, (2007). Evaluation report of food additives: polysorbates (polysorbate 20, polysorbate 60, polysorbate 65 and polysorbate 80) 1–33.
   Google Scholar
• Fredrikzon B, Olivecrona T. (1978). Decrease of lipase and esterase activities in intestinal contents of newborn infants during test meals. Pediatr Res 12:631–4.
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. (1998). Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles SLN™ dispersion. Int J Pharm 168:221–9.
   Web of Science ®Google Scholar
• Gasco MR. (1997). Solid lipid nanospheres from warm microemulsions. Pharm Technol Eur 9:52–8.
   Google Scholar
• Gonçalves LMD, Maestrelli F, Mannelli LC, et al. (2016). Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide. Eur J Pharm Biopharm 102:41–50.
   PubMed Web of Science ®Google Scholar
• Gopinathan S, O’Neill E, Rodriguez LA, et al. (2013). In vivo toxicology of excipients commonly employed in drug discovery in rats. J Pharm Toxicol Methods 68:284–95.
   PubMed Web of Science ®Google Scholar
• Hamosh M, Bitman J, Liao TH, et al. (1989). Gastric lipolysis and fat absorption in preterm infants: effect of medium-chain triglyceride or long-chain triglyceride containing formulas. Pediatrics 83:86–92.
   PubMed Web of Science ®Google Scholar
• Hamosh M, Scanlon JW, Ganot D, et al. (1981). Fat digestion in the newborn. Characterization of lipase in gastric aspirates of premature and term infants. J Clin Invest 67:838–46.
   PubMed Web of Science ®Google Scholar
• Johnson K, Ross L, Miller R, et al. (2013). Pancreatic lipase-related protein 2 digests fats in human milk and formula in concert with gastric lipase and carboxyl ester lipase. Pediatr Res 74:127–32.
   PubMed Web of Science ®Google Scholar
• Kamstrup D, Berthelsen R, Sassene PJ, et al. (2017). In vitro model simulating gastro-intestinal digestion in the pediatric population (neonates and young infants). AAPS Pharm Sci Tech 18:317–29.
   PubMed Web of Science ®Google Scholar
• Kasongo KW, Pardeike J, Müller RH, Walker RB. (2011). Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Sci 100:5185–96.
   PubMed Web of Science ®Google Scholar
• Luo Y, Teng Z, Li Y, Wang Q. (2015). Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr Polym 122:221–9.
   PubMed Web of Science ®Google Scholar
• McGrath JC, Lilley E. (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172:3189–93.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–96.
   PubMed Web of Science ®Google Scholar
• Mollica JA, Rehm CR, Smith JB, Govan HK. (1971). Hydrolysis of benzothiadiazines. J Pharm Sci 60:1380–4.
   PubMed Web of Science ®Google Scholar
• Moreau H, Laugier R, Gargouri Y, et al. (1988). Human preduodenal lipase is entirely of gastric fundic origin. Gastroenterology 95:1221–6.
   PubMed Web of Science ®Google Scholar
• Morishita M, Barichello JM, Takayama K, et al. (2001). Pluronic®F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin. Int J Pharm 212:289–93.
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Muller RH. (2008). Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 34:1394–405.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. (2009). Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 71:349–58.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 50:161–77.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8.
   PubMed Web of Science ®Google Scholar
• Nguyen TTP, Bhandari B, Cichero J, Prakash S. (2015). A comprehensive review on in vitro digestion of infant formula. Food Res Int 76:373–86.
   PubMed Web of Science ®Google Scholar
• Nnamani PO, Hansen S, Windbergs M, Lehr C-M. (2014). Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Int J Pharm 477:208–17.
   PubMed Web of Science ®Google Scholar
• Olah NK, Radu L, Mogoşan C, et al. (2003). Phytochemical and pharmacological studies on Orthosiphon stamineus Benth. (Lamiaceae) hydroalcoholic extracts. J Pharm Biomed Anal 33:117–23.
   PubMed Web of Science ®Google Scholar
• Padhye SG, Nagarsenker MS. (2013). Simvastatin: solid lipid nanoparticles for oral delivery: formulation development and in vivo evaluation. Indian J Pharm Sci 75:591–8.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. (2009). Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine: Nanotech Biol Med 5:184–91.
   PubMed Web of Science ®Google Scholar
• Pandolfini C, Bonati M. (2005). A literature review on off-label drug use in children. Eur J Pediatr 164:552–8.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366:170–84.
   PubMed Web of Science ®Google Scholar
• Patel RB, Patel UR, Rogge MC, et al. (1984). Bioavailability of hydrochlorothiazide from tablets and suspensions. J Pharm Sci 73:359–61.
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A. (2007). Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev 59:411–8.
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A, Müller RH. (2006). Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability. Pharmazie 61:425–30.
   PubMed Web of Science ®Google Scholar
• Radtke M, Müller RH. (2001). Nanostructured lipid carriers. New Drugs 2:48–52.
   Google Scholar
• Radtke M, Souto EB, Müller RH. (2005). Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Tech Eur 17:45–50.
   Google Scholar
• Reich G. (1997). In vitro stability of Poly(D, L-lactide) and Poly(D, L-lactide)/poloxamer nanoparticles in gastrointestinal fluids. Drug Dev Ind Pharm 23:1191–200.
   Web of Science ®Google Scholar
• Roger E, Lagarce F, Benoit JP. (2009). The gastrointestinal stability of lipid nanocapsules. Int J Pharm 379:260–5.
   PubMed Web of Science ®Google Scholar
• Roman C, Carriere F, Villeneuve P, et al. (2007). Quantitative and qualitative study of gastric lipolysis in premature infants: do MCT-enriched infant formulas improve fat digestion? Pediatr Res 61:83–8.
   PubMed Web of Science ®Google Scholar
• Santoveña A, Hernández-Paiz Z, Fariña JB. (2012). Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide. Int J Pharm 423:360–4.
   PubMed Web of Science ®Google Scholar
• Saupe A, Wissing SA, Lenk A, et al. (2005). Solid lipid nanoparticles (SLN) and nanostructured lipid car- riers (NLC)-structural investigations on two different carrier systems. Biomed Mater Eng 15:393–402.
   PubMed Web of Science ®Google Scholar
• Severino P, Andreani T, Macedo AS, et al. (2012). Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J. Drug Deliv 2012:1.
   Google Scholar
• Shah B, Khunt D, Bhatt H, et al. (2016). Intranasal delivery of venlafaxine loaded nanostructured lipid carrier: risk assessment and QbD based optimization. J Drug Deliv Sci Tech 33:37–50.
   Web of Science ®Google Scholar
• Siekmann B, Westesen K. (1996). Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur J Pharm Biopharm 43:104–9.
   Google Scholar
• Silva AC, Kumar A, Wild W, et al. (2012). Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Int J Pharm 436:798–805.
   PubMed Web of Science ®Google Scholar
• Standing JF, Tuleu C. (2005). Paediatric formulations-getting to the heart of the problem. Int J Pharm 300:56–66.
   PubMed Web of Science ®Google Scholar
• Sullivan DW, Gad SC, Julien M. (2014). A review of the non-clinical safety of Transcutol®, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as pharmaceutical excipient. Food Chem Toxicol 72:40–50.
   PubMed Web of Science ®Google Scholar
• Wiebelhaus VD, Weinstock J, Maass AR, et al. (1965). The diuretic and natriuretic activity of triamterene and several related pteridines in the rat. J Pharmacol Exp Ther 149:397–403.
   PubMed Web of Science ®Google Scholar
• Zangenberg NH, Mullertz A, Kristensen HG, Hovgaard L. (2001). A dynamic in vitro lipolysis model. II: evaluation of the model. Eur J Pharm Sci 14:237–44.
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Müller RH. (2001). Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticles (SLNTM) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 52:203–10.
   PubMed Web of Science ®Google Scholar
• Zoppi G, Andreotti G, Pajno-Ferrara F, et al. (1972). Exocrine pancreas function in premature and full term neonates. Pediatr Res 6:880–6.
   PubMed Web of Science ®Google Scholar